established that resveratrol significantly suppresses high glucose-induced mesangial cell proliferation in diabetic nephropathy models by downregulating the p38 MAPK/TGF-β1 signaling pathway, consequently reducing FN1 secretion and ameliorating glomerulosclerosis and fibrosis [66]. Here, FN1 is linked to diabetic kidney disease.